EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systematic Pharmacology Combined With Experimental Validation Reveals the Apoptosis‐Related Mechanism of Simiao Yong′an (SMYA) Decoction Against Myocardial Ischemia‐Reperfusion Injury

Huanjie Fu iD, Eryue Liu iD, Hao Yu iD, Yisheng Zhao iD, Yongkang Gan iD, Jinhong Chen iD, Zhichao Liu iD

Cardiovascular Therapeutics · 2026-01 · 2026 (1)

DOI: 10.1155/cdr/4200440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 05.05.2026. Verfasst von Huanjie Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China, tjutcm.edu.cn. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Myocardial Reperfusion Injury, Apoptosis, Myocardial Infarction. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical and Health Science and Technology Development Project of Shandong Province, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Science & Technology Development Fund of Tianjin Education Commission for Higher Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

According to traditional Chinese medicine theory, acute myocardial infarction (AMI) is primarily associated with qi stagnation and blood stasis. Simiao Yong′an (SMYA) decoction is a well‐known prescription that clears heat, detoxifies, and promotes blood circulation. SMYA has been used in the treatment of ischemic heart diseases (IHD). However, further analysis is required to clarify the specific mechanisms through which SMYA improves AMI and to determine its therapeutic effects at different time points during the acute phase of myocardial infarction. Aim of This Study This study is aimed at investigating the protective effects of SMYA against AMI at various time points and to explore its underlying mechanisms. Materials and Methods The active ingredients in SMYA were identified through ultraperformance liquid chromatography‐quadrupole‐time‐of‐flight mass spectrometry (UPLC‐Q‐TOF/MS). An integrated in silico approach was employed to predict potential targets of these compounds, and target‐pathway associations were established by aligning the data with relevant databases. A cardiac ischemia/reperfusion (I/R) model in rats was created by ligating the left coronary artery, inducing ischemia for 45 min, and allowing for 24 h of reperfusion. SMYA treatment was administered for 7 days. Cardiac function was evaluated at different time points during the acute phase of myocardial infarction using echocardiography. Serum biochemical indexes were measured using a biochemical kit, and western blotting (WB) was used to analyze AKT, p‐AKT, PI3K, p‐PI3K, BAX, Bcl‐2, and caspase‐3 proteins.

Results

UPLC‐Q‐TOF/MS identified 25 components in SMYA, which were considered potential effective ingredients. Network analysis identified 161 key targets and 167 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways associated with SMYA, with the PI3K‐Akt pathway being notably prominent. Experimental validation demonstrated that SMYA significantly reduced the levels of creatine kinase isoenzyme (CK‐MB) and lactate dehydrogenase (LDH) in serum and improved left ventricular ejection fraction (LVEF) and fractional shortening (FS) after myocardial I/R injury in rats. Additionally, SMYA reduced myocardial cell apoptosis and activated the PI3K‐AKT pathway in a dose‐dependent manner. Molecular docking confirmed binding between SMYA components and AKT/BCL‐2.

Conclusion

This study elucidates the mechanisms underlying AMI and the molecular action of SMYA. SMYA alleviates I/R‐induced AMI in rats by activating the PI3K‐AKT pathway, suggesting its potential as a therapeutic target for myocardial remodeling. The dose‐ and time‐dependent protective effects of SMYA suggest that the PI3K‐AKT pathway and its downstream target BCL‐2 constitute promising therapeutic targets for novel interventions in AMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalMyocardial Reperfusion InjuryApoptosisMyocardial InfarctionMyocytes, CardiacAnimalsSignal TransductionMaleRats, Sprague-DawleyDisease Models, AnimalProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinaseVentricular Function, LeftApoptosis Regulatory ProteinsTime FactorsMolecular Docking SimulationRats

Stichwörter der Autor:innen

PI3K-AKTSimiao Yong′an decoctionacute myocardial infarctiontherapeutic targets of active compounds

Substanzen

Drugs, Chinese HerbalProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinaseApoptosis Regulatory Proteins

Autor:innen und Institutionen

  • Department of Cardiovascular, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China, tjutcm.edu.cn.
  • Department of Pharmacy, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China, tjtcm.cn.
  • National Clinical Research Center for Chinese Medicine, Acupuncture and Moxbustion, Tianjin, China, >.
  • Intensive Care Unit, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China, tjutcm.edu.cn.
  • Department of Vascular Surgery, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
  • School of Rehabilitation Medicine, Shandong Second Medical University, Weifang, Shandong Province, China.

ORCID-Profile: Huanjie Fu, Eryue Liu, Hao Yu, Yisheng Zhao, Yongkang Gan, Jinhong Chen, Zhichao Liu

Förderung

  • Medical and Health Science and Technology Development Project of Shandong Province
  • Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
  • Science & Technology Development Fund of Tianjin Education Commission for Higher Education

Zitieren

APA

Fu, H., Liu, E., Yu, H., Zhao, Y., Gan, Y., Chen, J., & Liu, Z. (2026). Systematic Pharmacology Combined With Experimental Validation Reveals the Apoptosis‐Related Mechanism of Simiao Yong′an (SMYA) Decoction Against Myocardial Ischemia‐Reperfusion Injury. Cardiovascular Therapeutics, 2026(1). https://doi.org/10.1155/cdr/4200440

Vancouver

Fu H, Liu E, Yu H, Zhao Y, Gan Y, Chen J, et al. Systematic Pharmacology Combined With Experimental Validation Reveals the Apoptosis‐Related Mechanism of Simiao Yong′an (SMYA) Decoction Against Myocardial Ischemia‐Reperfusion Injury. Cardiovascular Therapeutics. 2026;2026(1). doi:10.1155/cdr/4200440

BibTeX
@article{Fu2026,
  author = {Fu, Huanjie and Liu, Eryue and Yu, Hao and Zhao, Yisheng and Gan, Yongkang and Chen, Jinhong and Liu, Zhichao},
  title = {Systematic Pharmacology Combined With Experimental Validation Reveals the Apoptosis‐Related Mechanism of Simiao Yong′an (SMYA) Decoction Against Myocardial Ischemia‐Reperfusion Injury},
  journal = {Cardiovascular Therapeutics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/cdr/4200440}
}
Kostenlos starten →